Theriva Biologics, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Theriva Biologics, Inc. (TOVX) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $12.19 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $12.19M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $15.40M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $15.38M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $6.74M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | $12.19M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $15.40M 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $15.38M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $6.74M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $10.62M 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $15.50M 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $19.07M 10-Q · filed 2026-08-11 | |
| 2024-09-30 | $24.64M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $25.90M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $31.39M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $36.96M 10-K · filed 2026-03-12 | |
| 2023-09-30 | $41.15M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $45.02M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $47.85M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $51.83M 10-K · filed 2025-03-06 | |
| 2022-09-30 | $56.39M 10-Q · filed 2023-11-13 | $55.41M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $62.22M 10-Q · filed 2023-11-13 | $61.67M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $68.03M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $65.41M 10-K · filed 2024-03-25 | |
| 2021-09-30 | $70.56M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $73.73M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $76.82M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | -$7.54M 10-K · filed 2023-03-30 | |
| 2020-09-30 | -$8.80M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | -$6.85M 10-Q · filed 2021-11-03 | |
| 2020-03-31 | -$4.00M 10-Q · filed 2021-11-03 | |
| 2019-12-31 | -$1.06M 10-K · filed 2022-03-16 | |
| 2019-09-30 | $2.09M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $7.17M 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $10.65M 10-Q · filed 2020-11-10 | |
| 2018-12-31 | $14.16M 10-K · filed 2021-03-04 | |
| 2018-09-30 | -$5.68M 10-Q · filed 2019-11-04 | |
| 2018-06-30 | -$8.43M 10-Q · filed 2019-11-04 | |
| 2018-03-31 | -$5.11M 10-Q · filed 2019-11-04 | |
| 2017-12-31 | -$3.41M 10-K · filed 2020-02-20 | |
| 2017-09-30 | -$6.66M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $2.96M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $761.00K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $2.26M 10-K · filed 2019-02-27 | $2.25M 10-K · filed 2017-03-02 |
| 2016-09-30 | -$5.98M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $931.00K 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $4.98M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $15.00M 10-K · filed 2018-02-22 | |
| 2015-09-30 | $25.14M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | -$13.66M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | -$1.63M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $9.56M 10-K · filed 2018-02-22 | |
| 2014-09-30 | $3.76M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $8.06M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $11.76M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $15.23M 10-K · filed 2017-03-02 | |
| 2012-12-31 | $13.03M 10-K · filed 2016-03-10 | |
| 2011-12-31 | $7.06M 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |